These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2846694)

  • 1. IFN-beta production by macrophages obtained from mice undergoing graft vs host disease.
    Cleveland MG; Ramirez RB; Klimpel GR
    J Immunol; 1988 Dec; 141(11):3823-7. PubMed ID: 2846694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease.
    Cleveland MG; Annable CR; Klimpel GR
    J Immunol; 1988 Nov; 141(10):3349-56. PubMed ID: 3141498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression and lymphoid hypoplasia associated with chronic graft versus host disease is dependent upon IFN-gamma production.
    Klimpel GR; Annable CR; Cleveland MG; Jerrells TR; Patterson JC
    J Immunol; 1990 Jan; 144(1):84-93. PubMed ID: 2104894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous IFN-beta production. A common feature of natural suppressor systems.
    Cleveland MG; Lane RG; Klimpel GR
    J Immunol; 1988 Sep; 141(6):2043-9. PubMed ID: 2971719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell regulation of interferon-alpha/beta (IFN-alpha/beta) production by alloantigen-stimulated bone marrow cells.
    Reyes VE; Klimpel KD; Klimpel GR
    J Immunol; 1985 May; 134(5):3137-41. PubMed ID: 2858508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
    Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
    Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages.
    Blanchard DK; Djeu JY; Klein TW; Friedman H; Stewart WE
    J Immunol; 1986 Feb; 136(3):963-70. PubMed ID: 2867114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ity influences the production of IFN-gamma by murine splenocytes stimulated in vitro with Salmonella typhimurium.
    Ramarathinam L; Niesel DW; Klimpel GR
    J Immunol; 1993 May; 150(9):3965-72. PubMed ID: 8473743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of human natural interferon-producing cells stimulated by tumor cell lines.
    Rönnblom L; Ramstedt U; Alm GV
    Eur J Immunol; 1983 Jun; 13(6):471-6. PubMed ID: 6574913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.
    Ilan Y; Margalit M; Ohana M; Gotsman I; Rabbani E; Engelhardt D; Nagler A
    Hum Immunol; 2005 Mar; 66(3):231-40. PubMed ID: 15784461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages.
    Ramarathinam L; Niesel DW; Klimpel GR
    J Immunol; 1993 May; 150(9):3973-81. PubMed ID: 8473744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells.
    Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K
    J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased IL-6 production and IL-6-mediated Ig secretion in murine host-vs-graft disease.
    Vandenabeele P; Abramowicz D; Berus D; Van der Heyden J; Grooten J; Donckier V; Hooghe-Peters EL; Goldman M; Fiers W
    J Immunol; 1993 May; 150(9):4179-87. PubMed ID: 8473756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide.
    Munakata T; Semba U; Shibuya Y; Kuwano K; Akagi M; Arai S
    J Immunol; 1985 Apr; 134(4):2449-55. PubMed ID: 3919096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.
    Kuwatani M; Ikarashi Y; Iizuka A; Kawakami C; Quinn G; Heike Y; Yoshida M; Asaka M; Takaue Y; Wakasugi H
    Immunol Lett; 2006 Jul; 106(1):82-90. PubMed ID: 16806496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
    Jones SC; Friedman TM; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.